ZIG
ABBV icon

Zuckerman Investment Group’s AbbVie ABBV Stock Holding History

Zuckerman Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.3M Buy
130,138
+1,654
+1% +$367K 2.65% 10
2025
Q4 		$29.4M Buy
128,484
+44,104
+52% +$10M 2.62% 7
2025
Q3 		$19.5M Buy
84,380
+5,695
+7% +$1.16M 1.81% 20
2025
Q2 		$14.6M Buy
78,685
+1,395
+2% +$259K 1.42% 29
2025
Q1 		$16.2M Buy
77,290
+900
+1% +$175K 1.74% 26
2024
Q4 		$14.5M Sell
76,390
-185
-0.2% -$34K 1.39% 30
2024
Q3 		$15.1M Buy
76,575
+446
+0.6% +$83.2K 1.55% 26
2024
Q2 		$13.1M Buy
76,129
+100
+0.1% +$16.6K 1.51% 29
2024
Q1 		$13.8M Buy
76,029
+3,361
+5% +$579K 1.57% 29
2023
Q4 		$11.3M Sell
72,668
-504
-0.7% -$73.5K 1.45% 32
2023
Q3 		$10.9M Sell
73,172
-2,514
-3% -$369K 1.56% 29
2023
Q2 		$10.2M Buy
75,686
+1,914
+3% +$281K 1.46% 29
2023
Q1 		$11.8M Sell
73,772
-265
-0.4% -$40.5K 1.79% 24
2022
Q4 		$12M Sell
74,037
-1,451
-2% -$222K 1.89% 19
2022
Q3 		$10.1M Buy
75,488
+4,037
+6% +$579K 1.9% 23
2022
Q2 		$10.9M Hold
71,451
– – 1.99% 23
2022
Q1 		$11.6M Sell
71,451
-1,250
-2% -$182K 1.87% 22
2021
Q4 		$9.84M Hold
72,701
– – 1.53% 27
2021
Q3 		$7.84M Hold
72,701
– – 1.3% 31
2021
Q2 		$8.19M Sell
72,701
-1,370
-2% -$154K 1.29% 32
2021
Q1 		$8.02M Hold
74,071
– – 1.32% 32
2020
Q4 		$7.94M Hold
74,071
– – 1.46% 27
2020
Q3 		$6.49M Sell
74,071
-270
-0.4% -$25.4K 1.44% 27
2020
Q2 		$7.3M Sell
74,341
-4,474
-6% -$394K 1.73% 25
2020
Q1 		$6M Buy
78,815
+3,721
+5% +$317K 1.75% 26
2019
Q4 		$6.65M Hold
75,094
– – 1.39% 32
2019
Q3 		$5.69M Hold
75,094
– – 1.34% 32
2019
Q2 		$5.46M Hold
75,094
– – 1.21% 32
2019
Q1 		$6.05M Hold
75,094
– – 1.43% 29
2018
Q4 		$6.92M Hold
75,094
– – 1.92% 24
2018
Q3 		$7.1M Hold
75,094
– – 1.55% 26
2018
Q2 		$6.96M Sell
75,094
-350
-0.5% -$34.2K 1.63% 23
2018
Q1 		$7.14M Sell
75,444
-184
-0.2% -$20.2K 1.83% 20
2017
Q4 		$7.31M Hold
75,628
– – 1.83% 19
2017
Q3 		$6.72M Sell
75,628
-705
-0.9% -$53.7K 1.65% 19
2017
Q2 		$5.54M Hold
76,333
– – 1.48% 19
2017
Q1 		$4.97M Hold
76,333
– – 1.21% 23
2016
Q4 		$4.78M Hold
76,333
– – 1.17% 21
2016
Q3 		$4.81M Hold
76,333
– – 1.28% 21
2016
Q2 		$4.73M Hold
76,333
– – 1.26% 22
2016
Q1 		$4.36M Hold
76,333
– – 1.17% 21
2015
Q4 		$4.52M Hold
76,333
– – 1.07% 24
2015
Q3 		$4.15M Hold
76,333
– – 0.98% 28
2015
Q2 		$5.13M Hold
76,333
– – 1.15% 20
2015
Q1 		$4.47M Hold
76,333
– – 0.95% 26
2014
Q4 		$5M Hold
76,333
– – 1.06% 25
2014
Q3 		$4.41M Sell
76,333
-313
-0.4% -$17.4K 0.92% 28
2014
Q2 		$4.33M Sell
76,646
-634
-0.8% -$33.3K 0.93% 26
2014
Q1 		$3.97M Sell
77,280
-1,570
-2% -$79.3K 0.94% 25
2013
Q4 		$4.16M Buy
78,850
+900
+1% +$44.2K 0.98% 27
2013
Q3 		$3.49M Buy
77,950
+1,718
+2% +$76.2K 0.88% 28
2013
Q2 		$3.15M Buy
+76,232
New +$3.33M 0.82% 29

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zuckerman Investment Group's ABBV Position: Q1 2026 in Review

Zuckerman Investment Group increased its AbbVie (ABBV) stake by 1.3% in Q1 2026, buying an estimated $367K and bringing the position to 130,138 shares worth $28.3M. The position accounts for 2.65% of the portfolio, ranked #10.

Zuckerman Investment Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.4M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Zuckerman Investment Group held 130,138 shares of AbbVie worth $28.3M as of Q1 2026.
  • Zuckerman Investment Group bought 1,654 AbbVie shares in Q1 2026, an estimated $367K.
  • AbbVie made up 2.65% of Zuckerman Investment Group's portfolio in Q1 2026, its #10 holding.
  • Zuckerman Investment Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Zuckerman Investment Group's AbbVie position peaked at $29.4M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Zuckerman Investment Group's 13F filing for Q1 2026, filed 15 May 2026.